삼성서울병원

Ko En

방사선종양학과 최두호 교수

진료분야
유방암, 대장암, 특수방사선치료
진료일정 01 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 02 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
오전
오후

학력

학력
1995.02 고려대학교 의과대학원 졸업(박사)
1988.02 서울대학교 의과대학원 졸업 (석사)
1982.02 서울대학교 의과대학 의학과 졸업 (의학사)

경력

경력
2009.03 ~현재 성균관의대 방사선종양학교실 교수
2013.08 ~ 2017.03 삼성서울병원 암병원 양성자센터장
2009.10 ~ 2015.03 성균관의대 방사선종양학교실 주임교수
2009.09 ~ 2015.03 삼성서울병원 방사선종양학과 진료과장
2008.03 ~ 2009.02 삼성서울병원 방사선종양학과 임상교수
2003.09 ~ 2008.02 순천향의대 방사선종양학교실 교수
1998.03 ~ 2003.08 순천향의대 방사선종양학과 부교수
2001.03 ~ 2002.12 예일대학교병원 방사선종양학과 교환교수
1994.03 ~ 1998.02 순천향의대 방사선종양학과 조교수
1992.03 ~ 1994.02 경희의대 방사선종양학과 임상전임강사
1989.03 ~ 1992.02 가천의대 중앙길병원 방사선종양학과 전문의
1986.03 ~ 1989.02 서울대학교병원 방사선종양학과 전공의 수료
1985.05 ~ 1986.02 서울대학교병원 인턴 수료

학회활동

학회활동
2007.02 ~ 현재 대한의학협회지(JKMS) 편집위원
2005.09 ~ 현재 대한방사선종양학회 이사
2015.10 ~ 2017.09 대한방사선종양학회 회장
2007.09 ~ 2016.12 대한방사선종양학회지 편집위원장

수상이력

수상이력
2009.10 Soonchunhyang University
2008.04 The best academic award
2005.05 Korean Federation of Science and Technology Society
2005.01 Academic award
  • INT J MOL SCI 2020 10.3390/ijms21082691 Checkpoint Kinase 1 (CHK1) Inhibition Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to Proton Irradiation via Rad51 Downregulation Choi1, C; Cho, WK; Park, S; Shin, SW; Park, W; Kim, H; Choi, DH
    View PubMed
  • J BREAST CANC 2020 10.4048/jbc.2020.23.e14 Cervical Lymph Node Involvement above the Supraclavicular Fossa in Breast Cancer: Comparison with Stage IIIC (KROG 18-02) Kim1, JS; Kim, K; Shin, KH; Kim, JH; Ahn, SD; Kim, SS; Kim, YB; Chang, JS; Choi, DH; Park, W; Kim, TH; Chun, M; Cha, J; Kim, JH; Lee, DS; Lee, SY; Park, HJ
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.261 Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer Yoo1, GS; Park, HC; Yu, JI; Choi, DH; Cho, WK; Park, YS; Park, JO; Lim, HY; Kang, WK; Lee, WY; Kim, HC; Yun, SH; Cho, YB; Park, YA; Song, KD; Kim, SH; Ha, SY
    View PubMed
  • RADIAT ONCOL 2020 10.1186/s13014-020-1464-0 Optimal radiotherapy for patients with internal mammary lymph node metastasis from breast cancer Yang1, K; Kim, H; Choi, DH; Park, W; Noh, JM; Cho, WK
    View PubMed
  • BREAST 2020 10.1016/j.breast.2019.10.007 Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12) Kim1, JS; Kim, K; Jung, W; Shin, KH; Im, SA; Kim, HJ; Kim, YB; Chang, JS; Choi, DH; Park, YH; Kim, DY; Kim, TH; Choi, BO; Lee, SW; Kim, S; Kwon, J; Kang, KM; Chung, WK; Kim, KS; Nam, JH; Yoon, WS; Kim, JH; Cha, J; Oh, YK; Kim, IA
    View PubMed
  • BREAST 2020 10.1016/j.breast.2019.10.017 Outcome of breast-conserving treatment for axillary lymph node metastasis from occult breast cancer with negative breast MRI Kim1, H; Park, W; Kim, SS; Ahn, SJ; Kim, YB; Kim, TH; Kim, JH; Choi, JH; Park, HJ; Chang, JS; Choi, DH
    View PubMed
  • CLIN BREAST CANCER 2020 10.1016/j.clbc.2019.09.004 Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14) Kim1, K; Kim, SS; Shin, KH; Kim, JH; Ahn, SD; Choi, DH; Park, W; Lee, SY; Chun, M; Kim, JH; Kim, YB; Cha, J; Park, HJ; Lee, DS; Jung, W
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.575 Impact of Regions Nodal Irradiation or Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14) Kim1, K; Jeong, Y; Shin, KH; Kim, JH; Ahn, SD; Kim, SS; Suh, CO; Kim, YB; Choi, DH; Park, W; Cha, J; Chun, M; Lee, DS; Lee, SY; Kim, JH; Park, HJ; Jung, W
    View PubMed
  • CLIN BREAST CANCER 2019 10.1016/j.clbc.2019.04.003 The Characteristics of Local Recurrence After Breast-Conserving Surgery Alone for Malignant and Borderline Phyllodes Tumors of the Breast (KROG 16-08) Choi1, N; Kim, K; Shin, KH; Kim, Y; Moon, HG; Park, W; Choi, DH; Kim, SS; Do Ahn, S; Kim, TH; Chun, M; Kim, YB; Kim, S; Choi, BO; Kim, JH
    View PubMed
  • TUMORI 2019 10.1177/0300891618792476 Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in rectal cancer patients following neoadjuvant chemoradiotherapy Kim1, TG; Park, W; Kim, H; Choi, DH; Park, HC; Kim, SH; Cho, YB; Yun, SH; Kim, HC; Lee, WY; Lee, J; Kang, KM
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.423 Korean First Prospective Phase II Study, Feasibility of Prone Position in Postoperative Whole Breast Radiotherapy: A Dosimetric Comparison Chung1, Y; Yu, JI; Park, W; Choi, DH
    View PubMed
  • BREAST 2019 10.1016/j.breast.2019.06.005 Is higher dose radiation necessary for positive resection margin after breast-conserving surgery for breast cancer? Cho1, WK; Choi, DH; Park, W; Kim, H; Cha, H
    View PubMed
  • J CLIN MED 2019 10.3390/ijms20194943 Cyclin D1 is Associated with Radiosensitivity of Triple-Negative Breast Cancer Cells to Proton Beam Irradiation Choi1, C; Park, S; Cho, WK; Choi, DH
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e42 Gastric Complications after Adjuvant Radiotherapy for Breast Cancer Cho1, WK; Choi, DH; Park, W; Kim, H; Kim, S; Shin, MH; Cha, H
    View PubMed
  • BREAST J 2019 10.1111/tbj.13304 Heart-sparing radiotherapy with three-dimensional printing technology after mastectomy for patients with left breast cancer Yang1, K; Park, W; Ju, SG; Chung, Y; Choi, DH; Cha, H; Park, JY; Shin, JS; Na, CH
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.424 Comparison of Breast Conserving Surgery Followed by Radiation Therapy with Mastectomy Alone for Pathologic N1 Breast Cancer Patients in the Era of Anthracycline Plus Taxane-Based Chemotherapy: A Multicenter Retrospective Study (KROG 1418) Yoo1, GS; Park, W; Yu, JI; Choi, DH; Kim, YJ; Shin, KH; Wee, CW; Kim, K; Park, KR; Kim, YB; Ahn, SJ; Lee, JH; Kim, JH; Chun, M; Lee, HS; Kim, JS; Cha, J
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e25 The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes Cho1, WK; Park, W; Choi, DH; Kim, YB; Kim, JH; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ
    View PubMed
  • BREAST 2019 10.1016/j.breast.2019.02.010 Is tumor bed boost necessary in patients who achieved ypCR following neoadjuvant chemotherapy and breast conserving therapy? (KROG 12-05 and 16-16) Cho1, WK; Park, W; Choi, DH; Kim, YB; Su, CO; Shin, KH; Chie, EK; Kim, JH; Ahn, SD; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ; Shin, HS; Lee, HS; Lee, NK
    View PubMed
  • SURGERY 2019 10.1016/j.surg.2018.08.026 Tumor regression grade as a clinically useful outcome predictor in patients with rectal cancer after preoperative chemoradiotherapy Huh1, JW; Kim, HC; Kim, SH; Park, YA; Cho, YB; Yun, SH; Lee, WY; Park, HC; Choi, DH; Park, JO; Park, YS; Chun, HK
    View PubMed
  • J BREAST CANC 2019 10.4048/jbc.2019.22.e1 Central Nervous System Failure in Korean Breast Cancer Patients with HER2-Enriched Subtype: Korean Radiation Oncology Group 16-15 Multicenter Retrospective Study Kim1, K; Shin, KH; Kim, JH; Choi, DH; Park, W; Kim, YB; Kim, HJ; Kim, JH; Park, H; Lee, SY; Kim, J; Oh, DH; Kim, IA
    View PubMed
  • BREAST 2019 10.1016/j.breast.2018.11.004 Adjuvant radiation therapy in small ductal carcinoma in situ Cho1, WK; Choi, DH; Kim, H; Noh, JM; Park, W; Cha, H
    View PubMed
  • CLIN BREAST CANCER 2019 10.1016/j.clbc.2018.08.009 Role of Elective Nodal Irradiation in Patients With ypN0 After Neoadjuvant Chemotherapy Followed by Breast-Conserving Surgery (KROG 16-16) Cho1, WK; Park, W; Choi, DH; Kim, YB; kim, JH; Kim, SS; Kim, K; Kim, JH; Ahn, SJ; Lee, SY; Lee, J; Kim, SW; Kwon, J; Ahn, KJ
    View PubMed
  • HERED CANCER CLIN PR 2019 10.1186/s13053-018-0103-3 The association between non-breast and ovary cancers and BRCA mutation in first- and second-degree relatives of high-risk breast cancer patients: a large-scale study of Koreans Kim1, H; Choi, DH; Park, W; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Jung, BY
    View PubMed
  • BREAST CANCER RES TR 2019 10.1007/s10549-018-5015-4 Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea Ryu1, JM; Choi, HJ; Kim, I; Nam, SJ; Kim, SW; Yu, J; Lee, SK; Choi, DH; Park, YH; Kim, JW; Seo, JS; Park, JH; Lee, JE; Kim, SW
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2017.575 Breast Conservation Therapy versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23 Kim1, K; Park, HJ; Shin, KH; Kim, JH; Choi, DH; Park, W; Ahn, SD; Kim, SS; Kim, DY; Kim, TH; Kim, JH; Kim, J
    View PubMed
  • CLIN BREAST CANCER 2018 10.1016/j.clbc.2018.04.010 Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment Cho1, WK; Choi, DH; Park, W; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY; Ahn, S
    View PubMed
  • J GASTROINTEST SURG 2018 10.1007/s11605-018-3815-9 Prognostic Role of Carcinoembryonic Antigen Level after Preoperative Chemoradiotherapy in Patients with Rectal Cancer Huh1, JW; Yun, SH; Kim, SH; Park, YA; Cho, YB; Kim, HC; Lee, WY; Park, HC; Choi, DH; Park, JO; Park, YS; Chun, HK
    View PubMed
  • BREAST CANCER RES TR 2018 10.1007/s10549-018-4838-3 Malignant and borderline phyllodes tumors of the breast: a multicenter study of 362 patients (KROG 16-08) Choi1, N; Kim, K; Shin, KH; Kim, Y; Moon, HG; Park, W; Choi, DH; Kim, SS; Do Ahn, S; Kim, TH; Chun, M; Kim, YB; Kim, S; Choi, BO; Kim, JH
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.e37 Patterns of Practice in Radiotherapy for Breast Cancer in Korea Park1, HJ; Oh, DH; Shin, KH; Kim, JH; Choi, DH; Park, W; Suh, CO; Kim, YB; Ahn, SD; Kim, SS
    View PubMed
  • J BREAST CANC 2018 10.4048/jbc.2018.21.2.206 Which Patients with Left Breast Cancer Should be Candidates for Heart-Sparing Radiotherapy? Cho1, WK; Park, W; Choi, DH; Cha, H; Nam, SJ; Kim, SW; Lee, JE; Yu, J; Im, YH; Ahn, JS; Park, YH; Kim, JY
    View PubMed
  • PHYS MEDICA 2018 10.1016/j.ejmp.2018.04.008 High-precision quality assurance of robotic couches with six degrees of freedom Cheon1, W; Cho, J; Ahn, SH; Han, Y; Choi, DH
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2016.607 Redefining the Positive Circumferential Resection Margin by Incorporating Preoperative Chemoradiotherapy Treatment Response in Locally Advanced Rectal Cancer: A Multicenter Validation Study Lee1, JH; Chie, EK; Jeong, SY; Kim, TY; Kim, DY; Kim, TH; Kim, SY; Baek, JY; Chang, HJ; Kim, MJ; Park, SC; Oh, JH; Kim, SH; Lee, JH; Choi, DH; Park, HC; Kang, SB; Kim, JS
    View PubMed
  • BREAST 2018 10.1016/j.breast.2018.01.004 Comparison of failure patterns between tubular breast carcinoma and invasive ductal carcinoma (KROG 14-25) Cho1, WK; Choi, DH; Lee, J; Park, W; Kim, YB; Suh, CO; Shin, KH; Jeon, SH; Kim, K; Park, KR; Kim, JH; Ahn, SJ; Yoon, WS; Yang, DS; Kim, J; Lee, JH; Yea, JW
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0193904 Proton range verification in inhomogeneous tissue: Treatment planning system vs. measurement vs. Monte Carlo simulation Kim1, DH; Cho, S; Jo, K; Shin, E; Hong, CS; Han, Y; Suh, TS; Lim, DH; Choi, DH
    View PubMed
  • RADIAT PROT DOSIM 2017 10.1093/rpd/ncx056 MEASUREMENT OF NEUTRON AMBIENT DOSE EQUIVALENT IN PROTON RADIOTHERAPY WITH LINE-SCANNING AND WOBBLING MODE TREATMENT SYSTEM Lee1, S; Lee, C; Shin, EH; Cho, S; Kim, DH; Han, Y; Choi, DH; Ye, SJ; Kim, JS
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.22511 Elevated CEA is associated with worse survival in recurrent rectal cancer Cho1, WK; Choi, DH; Park, HC; Park, W; Yu, JI; Park, YS; Park, JO; Lim, HY; Kang, WK; Kim, HC; Cho, YB; Yun, SH; Lee, WY
    View PubMed
  • J BREAST CANC 2017 10.4048/jbc.2017.20.4.327 Selective Radiation Therapy for Ductal Carcinoma In Situ Following Breast-Conserving Surgery According to Age and Margin Width: Korean Radiation Oncology Group 11-04 and 16-02 Studies Kim1, K; Kim, JH; Kim, YB; Suh, CO; Shin, KH; Kim, JH; Kim, TH; Jung, SY; Choi, DH; Park, W; Ahn, SD; Kim, SS; Yea, JW; Kang, MK; Kim, DW; Kim, YJ
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.508 Postmastectomy Radiotherapy in Patients with pT1-2N1 Breast Cancer Treated with Taxane-Based Chemotherapy: A Retrospective Multicenter Analysis (KROG 1418) Kim1, YJ; Park, W; Ha, B; Park, B; Joo, J; Kim, TH; Park, IH; Lee, KS; Lee, ES; Shin, KH; Kim, H; Il Yu, J; Choi, DH; Huh, SJ; Wee, CW; Kim, K; Park, KR; Kim, YB; Ahn, SJ; Lee, JH; Kim, JH; Chun, M; Lee, HS; Kim, JS; Cha, JY
    View PubMed
  • PHYS MED BIOL 2017 10.1088/1361-6560/aa87fd Study on dependence of dose enhancement on cluster morphology of gold nanoparticles in radiation therapy using a body-centred cubic model Ahn1, SH; Chung, K; Shin, JW; Cheon, W; Han, Y; Park, HC; Choi, DH
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.382 Prognostic Impact of Elective Supraclavicular Nodal Irradiation for Patients with N1 Breast Cancer after Lumpectomy and Anthracycline Plus Taxane-Based Chemotherapy (KROG 1418): A Multicenter Case-Controlled Study Kim1, H; Park, W; Yu, JI; Choi, DH; Huh, SJ; Kim, YJ; Lee, ES; Lee, KS; Kang, HS; Park, IH; Shin, KH; Wee, CW; Kim, K; Park, KR; Kim, YB; Ahn, SJ; Lee, JH; Kim, JH; Chun, M; Lee, HS; Kim, JS; Cha, J
    View PubMed
  • ONCOTARGET 2017 10.18632/oncotarget.18618 Targeted exome sequencing of Korean triple-negative breast cancer reveals homozygous deletions associated with poor prognosis of adjuvant chemotherapy-treated patients Jeong1, HM; Kim, RN; Kwon, MJ; Oh, E; Han, J; Lee, SK; Choi, JS; Park, S; Nam, SJ; Gong, GY; Nam, JW; Choi, DH; Lee, H; Nam, BH; Choi, YL; Shin, YK
    View PubMed
  • ASIA-PAC J CLIN ONCO 2017 10.1111/ajco.12652 Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy Kim1, H; Park, W; Huh, SJ; Choi, DH; Noh, JM; Im, YH; Ahn, JS; Park, YH; Nam, SJ; Kim, SW; Lee, JE; Cho, EY
    View PubMed
  • QUAL LIFE RES 2017 10.1007/s11136-017-1526-4 Patient-reported symptoms of radiation dermatitis during breast cancer radiotherapy: a pilot study Lee1, J; Park, W; Choi, DH; Huh, SJ; Kim, IR; Kang, D; Cho, J
    View PubMed
  • Breast Cancer Res Treat. 2017 Feb;162(1):77-83. doi: 10.1007/s10549-017-4111-1. Epub 2017 Jan 12. Recurrence outcomes after omission of postoperative radiotherapy following breast-conserving surgery for ductal carcinoma in situ of the breast: a multicenter, retrospective study in Korea (KROG 16-02) Kim K11, Jung SY2, Shin KH3, Kim JH4, Han W5, Lee HB5, Huh SJ6, Choi DH6, Park W6, Ahn SD7, Kim SS7, Kim JH8, Suh CO9, Kim YB9, Kim IA4,10, Kim S4,11, Kim YJ1.
    View PubMed
  • Oncotarget. 2017 Jan 3;8(1):1796-1804. doi: 10.18632/oncotarget.12882. Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418) Kim H11, Park W2, Yu JI2, Choi DH2, Huh SJ2, Kim YJ3, Lee ES3, Lee KS3, Kang HS3, Park IH3, Shin KH4, Kim K5, Park KR5, Kim YB6, Ahn SJ7, Lee JH8, Kim JH9, Chun M10, Lee HS11, Kim JS12, Lee JY13.
    View PubMed
  • Sci Rep. 2017 Jan 19;7:40922. doi: 10.1038/srep40922. Development of patient-specific phantoms for verification of stereotactic body radiation therapy planning in patients with metallic screw fixation Oh D11, Hong CS1, Ju SG1, Kim M1, Koo BY1, Choi S1, Park HC1, Choi DH1, Pyo H1.
    View PubMed
  • Breast Cancer Res Treat. 2017 Jan;161(1):95-102. doi: 10.1007/s10549-016-4034-2. Epub 2016 Oct 25. Frequency of pathogenic germline mutation in CHEK2, PALB2, MRE11, and RAD50 in patients at high risk for hereditary breast cancer Kim H11, Cho DY2, Choi DH3,4, Oh M2, Shin I2, Park W5, Huh SJ5, Nam SJ6, Lee JE6, Kim SW6.
    View PubMed
  • Oncotarget. 2016 Sep 20;7(38):62676-62686. doi: 10.18632/oncotarget.10445. Prognostic significance of survivin in rectal cancer patients treated with surgery and postoperative concurrent chemo-radiation therapy Yu JI11, Lee H2, Park HC1, Choi DH1, Choi YL3, Do IG4, Kim HC5, Lee WY5, Yun SH5, Cho YB5, Huh JW5, Park YA6, Park YS6, Park JO6, Kim ST6, Park W1.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):955-61. doi: 10.4143/crt.2015.191. Epub 2016 Jan 19. Analysis of BRIP1 Variants among Korean Patients with BRCA1/2 Mutation-Negative High-Risk Breast Cancer Kim H11, Cho DY2, Choi DH3, Jung GH2, Shin I2, Park W3, Huh SJ3, Nam SJ4, Lee JE4, Gil WH4, Kim SW4.
    View PubMed
  • J Cancer Res Clin Oncol. 2016 Jun;142(6):1377-85. doi: 10.1007/s00432-016-2148-x. Epub 2016 Mar 24. Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer Oh BY11, Park YA1, Huh JW1, Cho YB1, Yun SH1, Lee WY1, Park HC2, Choi DH2, Park YS3, Kim HC4.
    View PubMed
  • Clin Breast Cancer. 2016 Jun;16(3):e15-21. doi: 10.1016/j.clbc.2015.11.008. Epub 2015 Dec 11. Limited Supraclavicular Radiation Field in Breast Cancer With >= 10 Positive Axillary Lymph Nodes Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
    View PubMed
  • J Breast Cancer. 2016 Jun;19(2):169-75. doi: 10.4048/jbc.2016.19.2.169. Epub 2016 Jun 24. Lymph Node Ratio as a Risk Factor for Locoregional Recurrence in Breast Cancer Patients with 10 or More Axillary Nodes Kim SW11, Choi DH2, Huh SJ2, Park W2, Nam SJ3, Kim SW3, Lee JE3, Im YH4, Ahn JS4, Park YH4.
    View PubMed
  • Medicine (Baltimore). 2016 Jan;95(3):e2582. doi: 10.1097/MD.0000000000002582. Mismatch Repair Gene Expression as a Predictor of Tumor Responses in Patients With Rectal Cancer Treated With Preoperative Chemoradiation Huh JW11, Kim HC, Kim SH, Park YA, Cho YB, Yun SH, Lee WY, Park HC, Choi DH, Park JO, Park YS, Chun HK.
    View PubMed
  • Tumori. 2016 Jan-Feb;102(1):114-21. doi: 10.5301/tj.5000439. Epub 2015 Oct 7. Clinical significance of mucinous rectal adenocarcinoma following preoperative chemoradiotherapy and curative surgery Kim TG11, Park W2, Choi DH2, Park HC2, Kim SH3, Cho YB4, Yun SH4, Kim HC4, Lee WY4, Lee J5, Park JO5, Park YS5, Lim HY5, Kang WK5, Chun HK6.
    View PubMed
  • Clin Breast Cancer. 2015 Dec;15(6):512-8. doi: 10.1016/j.clbc.2015.06.004. Epub 2015 Jun 18. Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments Yu JI11, Park W2, Choi DH1, Huh SJ1, Nam SJ3, Kim SW3, Lee JE3, Kil WH3, Im YH4, Ahn JS4, Park YH4, Cho EY5.
    View PubMed
  • Breast. 2015 Oct;24(5):637-41. doi: 10.1016/j.breast.2015.07.016. Epub 2015 Aug 14. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy Noh JM11, Kim KH2, Park W3, Suh CO4, Huh SJ1, Choi DH1, Keum KC2, Kim YB2.
    View PubMed
  • Technol Cancer Res Treat. 2015 Oct;14(5):525-9. doi: 10.7785/tcrt.2012.500415. Epub 2014 Nov 24. Incidental Findings on Simulation CT Images for Adjuvant Radiotherapy in Breast Cancer Patients Park JS11, Choi DH2, Huh SJ1, Park W1, Nam SJ3, Lee JE3, Kil WH3, Lee KS4.
    View PubMed
  • Clin Breast Cancer. 2015 Oct;15(5):353-61.e1-2. doi: 10.1016/j.clbc.2015.01.008. Epub 2015 Feb 7. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06) Yu JI11, Choi DH2, Huh SJ1, Cho EY3, Kim K4, Chie EK4, Ha SW4, Park IA5, Ahn SJ6, Lee JS7, Shin KH8, Kwon Y8, Kim YB9, Suh CO9, Koo JS10, Kim JH11, Jeong BG12, Kim IA13, Lee JH14, Park W1.
    View PubMed
  • Med Phys. 2015 Oct;42(10):6021-7. doi: 10.1118/1.4931411. A virtual simulator designed for collision prevention in proton therapy Jung H11, Kum O2, Han Y3, Park HC3, Kim JS3, Choi DH3.
    View PubMed
  • Fam Cancer. 2015 Sep;14(3):365-71. doi: 10.1007/s10689-015-9789-9. Heterozygous germline mutations in NBS1 among Korean patients with high-risk breast cancer negative for BRCA1/2 mutation Kim H11, Cho DY, Choi DH, Jung GH, Shin I, Park W, Huh SJ, Kim SW, Park SK, Lee JW, Nam SJ, Lee JE, Gil WH, Kim SW.
    View PubMed
  • J Breast Cancer. 2015 Sep;18(3):285-90. doi: 10.4048/jbc.2015.18.3.285. Epub 2015 Sep 24. Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast Park JS11, Choi DH1, Huh SJ1, Park W1, Kim YI2, Nam SJ3, Lee JE3, Kil WH3.
    View PubMed
  • Breast Cancer Res Treat. 2015 Aug;152(3):589-99. doi: 10.1007/s10549-015-3505-1. Epub 2015 Jul 23. Does internal mammary node irradiation affect treatment outcome in clinical stage II-III breast cancer patients receiving neoadjuv ant chemotherapy Kim KH11, Noh JM, Kim YB, Chang JS, Keum KC, Huh SJ, Choi DH, Park W, Suh CO.
    View PubMed
  • Oncology. 2015;89(1):14-22. doi: 10.1159/000371390. Epub 2015 Mar 11. Is Chemoradiotherapy Beneficial for Stage IV Rectal Cancer Huh JW11, Kim HC, Park HC, Choi DH, Park JO, Park YS, Park YA, Cho YB, Yun SH, Lee WY, Chun HK.
    View PubMed
  • Med Phys. 2015 May;42(5):2626-37. doi: 10.1118/1.4916663. Preclinical investigation for developing injectable fiducial markers using a mixture of BaSO4 and biodegradable polymer for proton therapy Ahn SH11, Gil MS2, Lee DS2, Han Y3, Park HC3, Sohn JW4, Kim HY5, Shin EH5, Yu JI3, Noh JM3, Cho JS3, Ahn SH3, Choi DH3.
    View PubMed
  • 없음 Feasibility of using Geant4 Monte Carlo simulation for IMRT dose calculations for the Novalis Tx with a HD-120 multi-leaf collimator
  • Clin Breast Cancer. 2015 Apr;15(2):e105-15. doi: 10.1016/j.clbc.2014.10.002. Epub 2014 Oct 12. Unique Characteristics and Failure Patterns of Metaplastic Breast Cancer in Contrast to Invasive Ductal Carcinoma: A Retrospective Multicenter Case-Control Study (KROG 13-07) Yu JI11, Choi DH2, Huh SJ1, Ahn SJ3, Lee JS4, Shin KH5, Kwon Y5, Kim YB6, Suh CO6, Kim JH7, Cho J8, Kim IA9, Lee JH10, Park W1.
    View PubMed
  • J Surg Oncol.?2015 Mar 15;111(4):439-44. doi: 10.1002/jso.23835. Epub 2014 Dec 9. Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Curative Resection for Rectal Cancer: Is it Necessary for all Patients Jung KU11,?Kim HC,?Park JO,?Park YS,?Park HC,?Choi DH,?Cho YB,?Yun SH,?Lee WY,?Chun HK.
    View PubMed
  • J Breast Cancer. 2015 Mar;18(1):50-6. doi: 10.4048/jbc.2015.18.1.50. Epub 2015 Mar 27. Proportion and Clinical Outcomes of Postoperative Radiotherapy Omission after Breast-Conserving Surgery in Women with Breast Cancer Yu JI11, Choi DH1, Huh SJ1, Park W1, Nam SJ2, Kim SW2, Lee JE2, Kil WH2, Im YH3, Ahn JS3, Park YH3.
    View PubMed
  • Med Phys. 2015 Feb;42(2):1071-9. doi: 10.1118/1.4906131. Development of a 3D optical scanning-based automatic quality assurance system for proton range compensators Kim M11, Ju SG1, Chung K1, Hong CS1, Kim J2, Kim J1, Ahn SH1, Jung SH1, Han Y1, Chung Y1, Cho S1, Shin D3, Choi DH1.
    View PubMed
  • Yonsei Med J. 2015 Jan;56(1):82-8. doi: 10.3349/ymj.2015.56.1.82. Immunohistochemical Detection of p53 Expression in Patients with Preoperative Chemoradiation for Rectal Cancer: Association with Prognosis Huh JW11, Lee WY2, Kim SH3, Park YA1, Cho YB1, Yun SH1, Kim HC1, Park HC4, Choi DH4, Park JO5, Park YS5, Chun HK6.
    View PubMed
  • Breast. 2014 Oct;23(5):586-90. doi: 10.1016/j.breast.2014.05.025. Epub 2014 Jun 23. Excision alone for small size ductal carcinoma in situ of the breast Kim H11, Noh JM2, Choi DH3, Lee J4, Nam SJ5, Lee JE5, Park W4, Huh SJ4.
    View PubMed
  • BMC?Cancer.?2014 Sep 1;14:645. doi: 10.1186/1471-2407-14-645. A multi-institutional study of the prevalence of BRCA1 and BRCA2 large genomic rearrangements in familial breast cancer patients Seong MW1,?Cho SI,?Kim KH,?Chung IY,?Kang E,?Lee JW,?Park SK,?Lee MH,?Choi DH,?Yom CK,?Noh WC,?Chang MC,?Park SS,?Kim SW1;?Korean HereditaryBreast Cancer?Study?Group.
    View PubMed
  • Colorectal Dis. 2014 Aug;16(8):O257-63. doi: 10.1111/codi.12554. The adequacy of the distal resection margin after preoperative chemoradiotherapy for rectal cancer Kim TG11, Park W, Choi DH, Kim SH, Kim HC, Lee WY, Park JO, Park YS.
    View PubMed
  • Cancer Res Treat. 2014 Jul;46(3):243-9. doi: 10.4143/crt.2014.46.3.243. Epub 2014 Jul 15. Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically 12 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06) Noh JM11, Park W, Kim JS, Koom WS, Kim JH, Choi DH, Park HC.
    View PubMed
  • Breast Cancer Res Treat. 2014 Jul;146(2):341-5. doi: 10.1007/s10549-014-3025-4. Epub 2014 Jun 18. Influence of boost radiotherapy in patients with ductal carcinoma in situ breast cancer: a multicenter, retrospective study in Korea (KROG 11-04) Kim JH11, Choi DH, Park W, Ahn SD, Kim SS, Ha SW, Kim K, Kim YB, Yea JW, Kang MK, Shin KH, Kim DW, Lee JH, Suh CO.
    View PubMed
  • J Radiat Res. 2014 May;55(3):553-8. doi: 10.1093/jrr/rrt141. Epub 2014 Jan 1. Comparison of acute skin reaction following morning versus late afternoon radiotherapy in patients with breast cancer who have undergone curative surgical resection Noh JM11, Choi DH, Park H, Huh SJ, Park W, Seol SW, Jeong BK, Nam SJ, Lee JE, Kil WH.
    View PubMed
  • Cancer Genet. 2014 Apr;207(4):160-3. doi: 10.1016/j.cancergen.2014.04.002. Epub 2014 Apr 12. Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population Noh JM11, Choi DH2, Baek H3, Kim MJ4, Park H1, Huh SJ1, Park W1, Nam SJ5, Lee JE5, Kil WH5, Haffty BG6.
    View PubMed
  • Cancer?Res Treat.?2014 Apr;46(2):158-64. doi: 10.4143/crt.2014.46.2.158. Epub 2014 Apr 22. Clinical Outcomes of Local Excision Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Lee NK11,?Kim DY2,?Kim SY3,?Oh JH3,?Park W4,?Choi DH4,?Nam TK5,?Lee KJ6.
    View PubMed
  • J Appl Clin Med Phys.?2014 Mar 6;15(2):4556. doi: 10.1120/jacmp.v15i2.4556. Evaluation of radiation dose to organs during kilovoltage cone-beam computed tomography using Monte Carlo simulation Son K11,?Cho S,?Kim JS,?Han Y,?Ju SG,?Choi DH.
    View PubMed
  • Int J Colorectal Dis. 2014 Feb;29(2):193-200. doi: 10.1007/s00384-013-1797-3. Epub 2013 Dec 10. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients Kim TG11, Park W, Choi DH, Park HC, Kim SH, Cho YB, Yun SH, Kim HC, Lee WY, Lee J, Park JO, Park YS, Lim HY, Kang WK, Chun HK.
    View PubMed
  • Med Phys.?2014 Feb;41(2):021712. doi: 10.1118/1.4860155. Dosimetric effects of multileaf collimator leaf width on intensity-modulated radiotherapy for head and neck cancer Hong CS11,?Ju SG1,?Kim M1,?Kim JI2,?Kim JM1,?Suh TS3,?Han Y1,?Ahn YC1,?Choi DH1,?Nam H2,?Park HC1.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):453-8. doi: 10.1016/j.ijrobp.2013.10.024. Epub 2013 Dec 5. New Technique for Developing a Proton Range Compensator With Use of a 3-Dimensional Printer Ju SG11, Kim MK2, Hong CS2, Kim JS2, Han Y2, Choi DH2, Shin D3, Lee SB3.
    View PubMed
  • Int J Radiat Biol. 2014 Jan;90(1):90-4. doi: 10.3109/09553002.2013.835504. Epub 2013 Sep 19. Acute skin toxicity in Korean breast cancer patients carrying BRCA mutations Park H11, Choi DH, Noh JM, Huh SJ, Park W, Nam SJ, Lee JE.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):65-72. doi: 10.1016/j.ijrobp.2013.09.021. Epub 2013 Oct 22. The Role of Postmastectomy Radiation Therapy After Neoadjuvant Chemotherapy in Clinical Stage II-III Breast Cancer Patients With pN0: A Multicenter, Retrospective Study (KR0G 12-05) Shim SJ11, Park W2, Huh SJ3, Choi DH3, Shin KH4, Lee NK5, Suh CO6, Keum KC6, Kim YB6, Ahn SD7, Kim SS7, Ha SW8, Chie EK8, Kim K8, Shin HS9, Kim JH10, Lee HS11.
    View PubMed
  • Radiother Oncol. 2014 Jan;110(1):150-4. doi: 10.1016/j.radonc.2013.11.013. Epub 2014 Jan 7. Two-week course of preoperative chemoradiotherapy followed by delayed surgery for rectal cancer: A phase II multi-institutional clinical trial (KROG 11-02) Lee JH11, Kim JG2, Oh ST2, Lee MA3, Chun HG3, Kim DY4, Kim TH4, Kim SY4, Baek JY4, Park JW4, Oh JH4, Park HC5, Choi DH5, Park YS6, Kim HC7, Chie EK8, Jang HS9.
    View PubMed
  • J Breast Cancer. 2013 Dec;16(4):357-65. doi: 10.4048/jbc.2013.16.4.357. Epub 2013 Dec 31. Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer Kim H11, Choi DH2.
    View PubMed
  • Breast. 2013 Oct;22(5):894-7. doi: 10.1016/j.breast.2013.04.001. Epub 2013 May 3. HER-2 overexpression is not associated with increased ipsilateral breast tumor recurrence in DCIS treated with breast-conserving surgery followed by radiotherapy Noh JM11, Lee J, Choi DH, Cho EY, Huh SJ, Park W, Nam SJ, Lee JE, Kil WH.
    View PubMed
  • J Breast Cancer. 2013 Sep;16(3):308-14. doi: 10.4048/jbc.2013.16.3.308. Epub 2013 Sep 30. Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation Noh JM11, Han BK, Choi DH, Rhee SJ, Cho EY, Huh SJ, Park W, Park H, Nam SJ, Lee JE, Kil WH.
    View PubMed
  • Cancer Res Treat. 2013 Mar;45(1):48-54. doi: 10.4143/crt.2013.45.1.48. Epub 2013 Mar 31. Prognostic Value of Different Patterns of Squamous Cell Carcinoma Antigen Level for the Recurrent Cervical Cancer Jeong BK11, Huh SJ, Choi DH, Park W, Bae DS, Kim BG.
    View PubMed
  • Fam?Cancer.?2013 Mar;12(1):75-81. doi: 10.1007/s10689-012-9578-7. The prevalence of BRCA mutations among familial breast cancer patients in Korea: results of the Korean Hereditary Breast Cancer study Han SA11,?Kim SW,?Kang E,?Park SK,?Ahn SH,?Lee MH,?Nam SJ,?Han W,?Bae YT,?Kim HA,?Cho YU,?Chang MC,?Paik NS,?Hwang KT,?Kim SJ,?Noh DY,?Choi DH,Noh WC,?Kim LS,?Kim KS,?Suh YJ,?Lee JE,?Jung Y,?Moon BI,?Yang JH,?Son BH,?Yom CK,?Kim SY,?Lee H,?Jung SH;?KOHBRA Research?Group?and the?KoreanBreast Cancer?Society.
    View PubMed
  • Cancer?Sci.?2013 Jan;104(1):111-5. doi: 10.1111/cas.12041. Epub 2012 Nov 26. Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer Lee EM11,?Hong YS,?Kim KP,?Lee JL,?Kim SY,?Park YS,?Choi DH,?Kim JH,?Lim SB,?Yu CS,?Kim JC,?Lee JH,?Kim AY,?Kim TW.
    View PubMed
  • Cancer. 2012 Oct 15;118(20):4961-8. doi: 10.1002/cncr.27507. Epub 2012 Mar 13. Can the New American Joint Committee on Cancer Staging System Predict Survival in Rectal Cancer Patients Treated With Curative Surgery Following Preoperative Chemoradiotherapy Moon SH11, Kim DY, Park JW, Oh JH, Chang HJ, Kim SY, Kim TH, Park HC, Choi DH, Chun HK, Kim JH, Park JH, Yu CS.
    View PubMed
  • J Breast Cancer. 2012 Sep;15(3):283-7. doi: 10.4048/jbc.2012.15.3.283. Epub 2012 Sep 28. Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary Noh JM11, Choi DH, Baek H, Nam SJ, Lee JE, Kim JW, Ki CS, Park W, Huh SJ.
    View PubMed
  • Breast Cancer Res Treat. 2012 Aug;134(3):1315-26. doi: 10.1007/s10549-012-2159-5. Epub 2012 Jul 14. Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer Kim H11, Cho DY, Choi DH, Choi SY, Shin I, Park W, Huh SJ, Han SH, Lee MH, Ahn SH, Son BH, Kim SW; Korean Breast Cancer Study Group, Haffty BG.
    View PubMed
  • Breast Cancer?Res Treat.?2012 Jun;133(3):1143-52. doi: 10.1007/s10549-012-2001-0. Epub 2012 Mar 2. Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study Son BH11,?Ahn SH,?Kim SW,?Kang E,?Park SK,?Lee MH,?Noh WC,?Kim LS,?Jung Y,?Kim KS,?Noh DY,?Moon BI,?Suh YJ,?Lee JE,?Choi DH,?Kim SY,?Jung SH,?Yom CK,?Lee H,?Yang JH;?KOHBRA?Research?Group?and?Korean?Breast Cancer?Society.
    View PubMed
  • Med Phys. 2012 May;39(5):2396-404. doi: 10.1118/1.3700734. Development of a video-guided real-time patient motion monitoring system Ju SG11, Huh W, Hong CS, Kim JS, Shin JS, Shin E, Han Y, Ahn YC, Park HC, Choi DH.
    View PubMed
  • Breast Cancer Res Treat. 2012 Jan;131(1):217-22. doi: 10.1007/s10549-011-1718-5. Epub 2011 Aug 17. Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients Noh JM11, Choi DH, Nam SJ, Lee JE, Kim JW, Kim SW, Kang E, Lee MH, Ahn SH, Kim KS, Park SK, Haffty BG; Korea Breast Cancer Study Group.
    View PubMed
  • J Breast Cancer. 2011 Mar;14(1):46-51. doi: 10.4048/jbc.2011.14.1.46. Epub 2011 Mar 31. Patterns of Recurrence after Breast-Conserving Treatment for Early Stage Breast Cancer by Molecular Subtype Noh JM11, Choi DH, Huh SJ, Park W, Yang JH, Nam SJ, Im YH, Ahn JS.
    View PubMed
  • Incidence of Brain Metastasis and Related Subtypes in Patients with Breast Cancer Receiving Adjuvant Radiation Therapy after Surgery
  • Ann Surg.?2010 Dec;252(6):998-1004. doi: 10.1097/SLA.0b013e3181f3f1b1. Pathologic Complete Response of Primary Tumor Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Long-term Outcomes and Prognostic Significance of Pathologic Nodal Status (KROG 09-01) Yeo SG11,?Kim DY,?Kim TH,?Chang HJ,?Oh JH,?Park W,?Choi DH,?Nam H,?Kim JS,?Cho MJ,?Kim JH,?Park JH,?Kang MK,?Koom WS,?Kim JS,?Nam TK,?Chie EK,?Kim JS,?Lee KJ.
    View PubMed
  • 없음 The Change of Practice Patterns of the Hereditary Breast Cancer Management in Korea after the Korean Hereditary Breast Cancer Study
  • Breast Cancer Res Treat. 2010 Jul;122(1):303-6. doi: 10.1007/s10549-010-0806-2. Epub 2010 Mar 6. PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations Kim JH1, Choi DH, Cho DY, Ahn SH, Son BH, Haffty BG.
    View PubMed
  • Radiation Therapy for Colorectal Cancer
  • Breast. 2010 Jun;19(3):231-7. doi: 10.1016/j.breast.2010.01.020. Epub 2010 Mar 20. Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: Matched case-control study Yu JI11, Choi DH, Park W, Huh SJ, Cho EY, Lim YH, Ahn JS, Yang JH, Nam SJ.
    View PubMed
  • Ann Oncol. 2009 Oct;20(10):1653-9. doi: 10.1093/annonc/mdp051. Epub 2009 Jun 2. Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups Haffty BG11, Choi DH, Goyal S, Silber A, Ranieri K, Matloff E, Lee MH, Nissenblatt M, Toppmeyer D, Moran MS.
    View PubMed
  • 없음 The Breast and Ovarian Cancer Risks in Korea Due to Inherited Mutations in BRCA1 and BRCA2: A Preliminary Report
  • Breast Cancer Res Treat. 2008 Dec;112(3):569-73. doi: 10.1007/s10549-007-9878-z. Epub 2008 Jan 3. The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation Choi DH11, Cho DY, Lee MH, Park HS, Ahn SH, Son BH, Haffty BG.
    View PubMed